# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA676159 | B | Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK). | 54 | ALA1131018 | single protein format | Scientific Literature | ||
2. | ALA679949 | B | Evaluated for inhibitory activity towards tyrosine kinase Epidermal growth factor receptor | 20 | ALA1133768 | single protein format | Scientific Literature | ||
3. | ALA678589 | F | Inhibition of bFGF-mediated tyrosine phosphorylation | Homo sapiens | 3 | ALA1133506 | assay format | Scientific Literature | |
4. | ALA677830 | B | Inhibitory activity against Epidermal growth factor receptor | 23 | ALA1132535 | single protein format | Scientific Literature | ||
5. | ALA678670 | B | Evaluated for inhibitory activity towards Fibroblast growth factor receptor 1 | 20 | ALA1133768 | single protein format | Scientific Literature | ||
6. | ALA678671 | B | Inhibitory activity against Fibroblast growth factor receptor 1 | 23 | ALA1132535 | single protein format | Scientific Literature | ||
7. | ALA686676 | B | Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK) | 54 | ALA1131018 | single protein format | Scientific Literature | ||
8. | ALA880174 | F | Inhibitory activity against ligand-dependent EGF cell proliferation | 23 | ALA1132535 | assay format | Scientific Literature | ||
9. | ALA696130 | F | Inhibitory activity of compound against FGF induced cell proliferation | 23 | ALA1132535 | assay format | Scientific Literature | ||
10. | ALA871982 | F | Inhibitory activity of compound against PDGF induced cell proliferation | 23 | ALA1132535 | assay format | Scientific Literature | ||
11. | ALA696131 | F | Inhibitory activity of compound against VEGF induced cell proliferation | 23 | ALA1132535 | assay format | Scientific Literature | ||
12. | ALA693029 | F | Evaluated for the inhibition of cell proliferation induced by EGF in HUVEC or NIH3T3 cells | 20 | ALA1133768 | cell-based format | Scientific Literature | ||
13. | ALA693030 | F | Evaluated for the inhibition of cell proliferation induced by FGF in HUVEC or NIH3T3 cells | 20 | ALA1133768 | cell-based format | Scientific Literature | ||
14. | ALA693031 | F | Evaluated for the inhibition of cell proliferation induced by PDGF in HUVEC or NIH3T3 cells | 20 | ALA1133768 | cell-based format | Scientific Literature | ||
15. | ALA693032 | F | Evaluated for the inhibition of cell proliferation induced by VEGF in HUVEC or NIH3T3 cells | 20 | ALA1133768 | cell-based format | Scientific Literature | ||
16. | ALA697346 | B | Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Insulin-like growth factor I receptor | 54 | ALA1131018 | single protein format | Scientific Literature | ||
17. | ALA764822 | B | Evaluated for inhibitory activity towards tyrosine kinase PDGF-Rbeta | 20 | ALA1133768 | single protein format | Scientific Literature | ||
18. | ALA768947 | B | Test concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Platelet-derived growth factor receptor beta (PDGF RTK). | 54 | ALA1131018 | single protein format | Scientific Literature | ||
19. | ALA763441 | B | Inhibitory activity against Platelet-derived growth factor receptor beta | 23 | ALA1132535 | single protein format | Scientific Literature | ||
20. | ALA812787 | B | Evaluated for inhibitory activity towards tyrosine kinase Vascular endothelial growth factor receptor 2 | 20 | ALA1133768 | single protein format | Scientific Literature |